- Economic Development
- International Trade
- Science and Technology
- Taxation and Finance
Subject Matter Details
Policies or Program
- Advancing the recommendations made by the Health & Biosciences Economic Strategy Table to grow the medical technology industry in Canada.
- Discussions re. Policies to incent global medical technology companies to invest their R&D dollars in Canada, changes to the Scientific Research and Experimental Development tax credit and the impact on medical technology companies in Canada, the adoption of a common national framework to measuring health outcomes resulting in greater efficiencies and lower costs.
- Health Canada - Health Technology Assessment (HTA) and the role of the Canadian Agency for Drugs and Technologies in Health (CADTH), GS1 (Global Standards 1) Canada, Vendor Credentialing, the removal of regulatory barriers to build an innovation economy and provide funding to grow a Canadian Artificial Intelligence & Digital Health cluster that will be globally competitive.
- Innovation, Science and Economic Development Canada - advocating that the federal government work across all government relevant Ministries and with key stakeholders to advance the adoption of novel and innovative health innovations and grow the medical technology industry in Canada including forming a permanent cross ministerial and stakeholder collaborative roundtable/advisory group. Advocating for the development of a commercialization framework and adoption of medical technologies & health innovations strategy in Canada.
- Medical Device Bureau: discussions re. a program that assesses safety, effectiveness and quality of medical devices with respect to the authorization for the sale of medical device technologies in Canada.
- Environmental regulation of Medical Devices (Canadian Environment Protection Act (CEPA), Chemicals Management Plan, provincial Stewardship regulations), Addressing issues and providing advice related to Medical Devices concerned by these regulations and participation in legislative/regulatory processes with the intent of seeking reasonable approaches based on scientific evidence and revising policies where needed.
- Health Technology Assessment (HTA) - Providing advice and evidence related to the 'Value of Technology' in order to assist in the process of establishing proper medical device funding and reimbursement, contribution to the process of HTA with the intent of seeking reasonable approaches based on scientific evidence and changing reimbursement policies where needed.
- Medical Device Regulations (SOR/98-282) that require compliance by the medical device technology industry. Addressing issues and providing advice related to Medical Device Regulations in Canada; performance of Therapeutic Products Directorate, Health Canada; other related activities of Health Canada e.g. health protection legislative renewal, cost recovery/user fees, quality systems (ISO 13485), single-use device reuse, Regulatory Review of Drugs and Devices (R2D2). Participate in the legislative/regulatory process with the intent of seeking reasonable approaches based on scientific evidence and changing policies where needed.
Canada Revenue Agency (CRA)
Environment and Climate Change Canada (ECCC)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Office of the Commissioner of Lobbying (OCL)
Prime Minister's Office (PMO)
Public Services and Procurement Canada (PSPC)
In-house Organization Details
Description of the organization's activities
Medtech Canada is the national association representing the medical technology industry in Canada. Our association advocates for achieving patient access to leading edge, innovative technology solutions that provide valuable outcomes. Our members are committed to providing safe and innovative medical technologies that enhance the quality of patient care, improve patient access to health care, and help enable the sustainability of our health care system. The medical technology industry in Canada employs over 35,000 Canadians in approximately 1,500 facilities across the country.
Responsible officer name and position during the period of this registration
President & Chief Executive Officer
Organization's membership or classes of membership
Full Membership: Applies to companies engaged in the manufacturing and/or distribution of medical device and diagnostic products in Canada. Full members receive all benefits of membership, including voting privileges, information services, access to educational programs and seminars at a reduced cost, annual membership directory and eligibility to sit on the Board of Directors. Dues are based on prior year's domestic sales.
Allied Business Membership: Applies to consultants and service providers to the medical device industry. Allied Business members pay an annual flat fee.
Associate Membership: Applies to not for profit organizations that are valued partners of Medtech Canada and offer value to members. Associate members pay a flat annual fee.
Emerging Medical Technology (EMT): Applies to medical technology companies that are pre-commercialized. EMT members receive some of the same benefits as full members excluding voting privileges and eligibility to sit on the Board of Directors. These companies may become Full Members at any time by subscribing to the Full Member Fee Structure. EMT members pay an annual flat fee.
End date of the last completed financial year:
List of Government Funding
Funding Received in Last Financial Year
Funding Expected in Current Financial Year
Ministry of Economic Development -Quebec
Ministry of Labour Training and Skills Development - Ontario
In-house Organization Contact Information
900-405 The West Mall
Toronto, ON M9C 5J1
Employees who lobby for the organization
- Nicole DeKort,
President & CEO |
No public offices held
- Diana Johnson,
Vice President of Regulatory Affairs |
No public offices held
- Raj Malik,
Vice-President of Federal Affairs & Health Systems |
No public offices held